Listen to the data: COVID-19 Vaccines

Public health researchers are urging Australians to roll up their sleeves and get vaccinated against COVID-19.

Male patient receives vaccination

A barrage of headlines, low levels of community transmission, the level of scrutiny given to the cases of clots and very frequent revisions to the COVID-19 vaccination program have made for a heap of misinformation about AstraZeneca.

However, data is emerging that compares the effectiveness of the two COVID-19 vaccines in our vaccination program in the real world as opposed to clinical trials. 

A Public Health England study released this week, based on the rollout of AstraZeneca’s COVID-19 vaccine, demonstrated that one dose of the AstraZeneca vaccine results in 80 per cent lower risk of death from the disease.

A study from Scotland found a comparable reduction in COVID-19 hospital admissions post vaccination with both vaccines (Pfizer: 91 per cent v AstraZeneca: 88 per cent).

Based on these examples of real-life data, let’s flip the public messaging and highlight how many people receive the AstraZeneca without any issues and roll up our sleeves.

Read the full article here: Why the over-50s shouldn’t envy those who can get the Pfizer jab at Homebush [opens external site]

Byline

Holly Seale, University of New South Wales; Jane Frawley, University of Technology Sydney
Share
Share this on LinkedIn
Back to News in Health
Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.